<DOC>
	<DOCNO>NCT01153425</DOCNO>
	<brief_summary>The purpose study determine change trabecular bone architecture woman 60 old high risk fracture treat either teriparatide zoledronic acid .</brief_summary>
	<brief_title>Nuclear MRI ( NMR ) Women Risk Fracture Receiving Either Zoledronic Acid Teriparatide</brief_title>
	<detailed_description>The overall design determine compare effect teriparatide zoledronic acid trabecular architecture magnetic resonance microimaging midshaft tibia . Fifty-six postmenopausal woman , age 60 old osteoporosis and/or increase risk fracture , randomize receive either teriparatide zoledronic acid . Both group follow 24 month . Trabecular microarchitecture , cortical structural parameter , biomechanical parameter bone mineral density examine 0 , 12 , 24 month .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Women Age &gt; 60 year Bone mineral density Tscore either spine ( L1L4 ) , total hip femoral neck â‰¤ 2.0 , history osteoporotic fracture Previous treatment pamidronate , ibandronate , 2 dos 2 year zoledronic acid time Previous treatment teriparatide , alendronate risedronate 2 month last 24 month Previous treatment calcitonin within previous year . Previous treatment estrogen selective estrogen modulator exclude potential subject unless take &lt; 1 year ( woman discontinue estrogen selective estrogen receptor within previous year also exclude ) Other disease know affect bone , Paget 's disease , Cushing 's disease , hyperthyroidism , hyperparathyroidism , bone cancer metastases bone , vitamin D deficiency Medications know affect bone , anticonvulsant , high dose glucocorticoid ( 20 mg/day &gt; 2 week within previous 6 month ) Current alcohol use &gt; 3 drinks/day Untreated unstable cardiac , pulmonary , liver ( SGOT &gt; 2X upper limit normal ) renal disease ( creatinine &gt; 1.2 mg/dL ) uncontrolled diabetes ( hemoglobin A1C &gt; 8.0 ) . Prior radiation therapy skeleton Cardiac pacemaker , ferromagnetic implant brain aneurysm clip Claustrophobia Subjects whose initial MRI poor quality due motion artifact ask repeat examination . If repeat MRI poor quality due motion artifact , subject exclude study Abnormalities delay esophageal emptying stricture achalasia Inability stand sit upright least 30 minute Hypocalcemia Uric acid level &gt; 7.5ml/dl Subjects metallic object body</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Fracture Risk</keyword>
	<keyword>teriparatide Forteo</keyword>
	<keyword>zoledronic acid Reclast</keyword>
</DOC>